KIMBERLY PIERCE: Open Payments
NPI 1255721395 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 37 payments from 16 companies in 2025. Trend: 2023 $188 · 2024 $941 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $168 |
| Actelion Pharmaceuticals US, Inc. | 3 | $101 |
| GENZYME CORPORATION | 4 | $95 |
| United Therapeutics Corporation | 4 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Verona Pharma, Inc. | 2 | $39 |
| Insmed, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: DUPIXENT, TEZSPIRE, Tyvaso, OPSUMIT, Ohtuvayre, Arikayce, OPSYNVI, FASENRA.
Industry payments across SC — which companies pay providers there.
